(XEMD) Xtrackers MSCI Emerging - Ratings and Ratios
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: IE000GWA2J58
XEMD: Emerging Markets Equities
The Xtrackers MSCI Emerging Markets UCITS ETF 1D (XETRA:XEMD) is a Germany-domiciled ETF designed to track the performance of the Morningstar EM TME NR USD Index. This fund provides exposure to a broad range of emerging market equities, offering diversification across multiple regions and sectors. The ETF is part of the Xtrackers suite, known for its transparency and cost-effective replication of indices. It employs a full replication strategy, holding a representative sample of the underlying index constituents to closely align with its benchmark.
From a technical perspective, the ETF has shown a recent price of 6.79 EUR, with a 20-day average volume of 18,923 shares. The SMA 20 (6.76) is slightly below the current price, indicating short-term strength. The SMA 50 and SMA 200 both stand at 7.14, suggesting a potential resistance level. The ATR of 0.13 reflects moderate volatility, with price fluctuations remaining relatively contained over the past month.
Fundamentally, the ETF manages an AUM of 5.417 billion EUR, indicating significant investor interest and liquidity. The funds expense ratio is competitive, aligning it with other emerging market ETFs in its category. It also distributes dividends semi-annually, providing a modest income stream alongside potential capital appreciation.
3-Month Forecast: Based on the convergence of the SMA 50 and SMA 200 at 7.14, the ETF may face resistance at this level. The ATR of 0.13 suggests that volatility will remain subdued, with potential price fluctuations confined within a narrow range. If the SMA 20 crosses above the SMA 50, it could signal a bullish trend, targeting the 7.30-7.50 range. Conversely, a breakdown below the SMA 200 at 7.14 may lead to a retest of the 6.50 support level. The outlook leans neutral to slightly bullish, contingent on broader emerging market sentiment and macroeconomic conditions.
Additional Sources for XEMD ETF
XEMD ETF Overview
Market Cap in USD | 6,086m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2021-11-03 |
XEMD ETF Ratings
Growth Rating | 16.9 |
Fundamental | - |
Dividend Rating | 44.4 |
Rel. Strength | -18.3 |
Analysts | - |
Fair Price Momentum | 6.48 EUR |
Fair Price DCF | - |
XEMD Dividends
Dividend Yield 12m | 2.33% |
Yield on Cost 5y | 2.35% |
Annual Growth 5y | 8.74% |
Payout Consistency | 96.9% |
Payout Ratio | % |
XEMD Growth Ratios
Growth Correlation 3m | -3.1% |
Growth Correlation 12m | 37.5% |
Growth Correlation 5y | 39.1% |
CAGR 5y | 0.21% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | 0.46 |
Alpha | -2.68 |
Beta | 0.622 |
Volatility | 14.20% |
Current Volume | 117.9k |
Average Volume 20d | 42.4k |
As of June 01, 2025, the stock is trading at EUR 7.13 with a total of 117,929 shares traded.
Over the past week, the price has changed by -1.53%, over one month by +4.71%, over three months by -5.05% and over the past year by +5.52%.
Neither. Based on ValueRay´s Analyses, Xtrackers MSCI Emerging is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 16.91 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XEMD is around 6.48 EUR . This means that XEMD is currently overvalued and has a potential downside of -9.12%.
Xtrackers MSCI Emerging has no consensus analysts rating.
According to our own proprietary Forecast Model, XEMD Xtrackers MSCI Emerging will be worth about 7.3 in June 2026. The stock is currently trading at 7.13. This means that the stock has a potential upside of +2.95%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7.3 | 2.9% |